Armata Pharmaceuticals (ARMP) Institutional Ownership $1.89 +0.02 (+1.07%) Closing price 04:10 PM EasternExtended Trading$1.90 +0.02 (+0.79%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)2 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Bridgeway Capital Management LLC69,682$129K0.0%-7.6%0.193% 2/13/2025 Renaissance Technologies LLC40,291$75K0.0%-13.3%0.111% 4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021 Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021 Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021 Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021 Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021 Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021 Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021 Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021 Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/13/2021 Edgewood Management LLC50,000$239K0.0%+25.0%0.200% 5/12/2021 Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021 UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K), and Bridgeway Capital Management LLC ($129K), Renaissance Technologies LLC ($75K).Learn more on ARMP's institutional investors. What percentage of Armata Pharmaceuticals stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals stock? The following institutional investors have purchased Armata Pharmaceuticals stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 14,647 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Armata Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Armata Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($6.21K), and Bridgeway Capital Management LLC ($5.70K). How much institutional selling is happening at Armata Pharmaceuticals? Institutional investors have sold a total of 11,905 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies Ocugen Institutional Ownership Design Therapeutics Institutional Ownership CytomX Therapeutics Institutional Ownership Nuvectis Pharma Institutional Ownership Annexon Institutional Ownership Tiziana Life Sciences Institutional Ownership Y-mAbs Therapeutics Institutional Ownership Actuate Therapeutics Institutional Ownership Inventiva Institutional Ownership INmune Bio Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARMP Stock Free ARMP Stock Alerts